However, given that both studies have a limited number of samples and diverse analytical strategies, it cannot be assumed that NEFH is one of the most promising prognostic biomarker candidates in HPV-positive HNSCC, so further evidence to support this claim is required. The gene discussed is NEFH; the disease is head and neck squamous cell carcinoma.